Preliminary data from researchers at the University of Pittsburgh Medical Center showed that naltrexone reduced both pain and disability in chronic pain patients when administered in low doses, according to a media report.
A study by researchers at Oregon Health & Science University and the Oregon State University College of Pharmacy found that 1 in 5 pharmacies refuse to dispense Suboxone, the medication that combines buprenorphine and naloxone.
The Department of Health and Human Services announced on Tuesday it is releasing a new version of its Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that will allow nearly all prescribers to treat opioid use disorder with buprenorphine.
Concurrent with a rise in opioid overdose deaths, fewer new patients received buprenorphine prescriptions for the treatment of opioid use disorder during the early months of the COVID-19 pandemic, according to researchers at Princeton University.
Spectrum Health Systems announced that it has been awarded a four-year, $43.5 million contract by the Massachusetts Department of Correction to provide medication-assisted treatment to incarcerated offenders.
Researchers at Temple University have received a $1.77 million grant from the National Institute on Drug Abuse to study the effects of a therapy for the treatment of cocaine use disorder, according to a media report.
With the far reach of the opioid epidemic and the high comorbidity of opioid addiction with other psychiatric disorders, the session will be relevant to all attendees, not just those in addiction medicine.
During the opening plenary of NCAD West on Thursday, Colorado Consortium for Prescription Drug Abuse director Rober Valuck, PhD, RPh, FNAP, implored attendees to aggressively fight barriers to treatment, scrutinize their own work, and learn from their peers.